Skip to content
Search

Latest Stories

RPS hires communications agency Luther Pendragon to review member participation

The Royal Pharmaceutical Society (RPS) has appointed communications agency to lead a review into how it can develop and strengthen member participation.

"We've appointed communications consultancy Luther Pendragon to carry out an independent review of the participation of members and of our communications concerning decisions we take on behalf of the profession through our Governance boards," the Society said in a statement on Tuesday (May 10).


It added that review would examine how RPS members, elected members and stakeholders can feel engaged, informed and empowered to influence decisions about RPS policy and understand why decisions around organizational policy have been taken on their behalf by elected representatives.

It will also ensure RPS decision-making processes are open and transparent with an emphasis on evidence-based decision making, and recommend ways elected members are enabled to be publicly accountable for decisions taken by the organization at Board and Assembly level.

Luther Pendragon will conduct in-depth reviews -- seeking views of members and elected members as well as individuals and organizations outside the profession, about how participation can be developed and strengthened.

The agency will use a combination of focus groups, online surveys and one-to-one interviews to build a detailed understanding of views, on which to base a series of recommendations for the RPS.

Luther will then develop a corporate communications strategy which will include action plans for each of the RPS’s target audiences in order to enable greater participation.

RPS committed to making changes

RPS president Professor Claire Anderson said: “Now we have appointed Luther Pendragon and have a robust review process in place we can build a new approach to participation and communications with our members, elected members and stakeholders.

“I look forward to hearing your views and building them into the independent review, which we will publish when it is complete. I am committed to making changes based on its recommendations.”

Part of the Crown Commercial Service, Luther Pendragon has worked with various pharmacy organizations, NHS England, and the Department of Health & Social Care.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less